Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
J Chromatogr B Biomed Sci Appl ; 753(1): 17-22, 2001 Mar 25.
Article in English | MEDLINE | ID: mdl-11302442

ABSTRACT

A His-tag recombinant carboxyl half part of the HTLV-I surface envelope glycoprotein was overexpressed in E. coli as a secreted form in order to study its biochemical properties and to determine its three-dimensional structure by X-ray crystallography. Starting from several hundred milliliters of culture, a centrifugation was used to eliminate the cells. After solubilization and centrifugation, the protein was then purified by a one-step chromatographic purification procedure. Immobilized Metal Affinity Chromatography (IMAC) was performed by evaluating the tri-dentate iminodiacetic acid (IDA) chelating group with chelating Sepharose fast flow, and the tetra-dendate nitrilotriacetic acid (NTA) chelating group with NTA-agarose. The latter was the most suitable gel for our protein. This expression system and the use of affinity chromatography is a rapid technique to obtain a soluble protein for use in structural studies to further understand the mechanisms of HTLV-1 entry into target cells.


Subject(s)
Chromatography, Affinity/methods , Gene Products, env/chemistry , Histidine/chemistry , Peptide Fragments/isolation & purification , Retroviridae Proteins, Oncogenic/chemistry , Chelating Agents/chemistry , Electrophoresis, Polyacrylamide Gel , Escherichia coli/genetics , Peptide Fragments/chemistry , Peptide Fragments/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification
2.
AIDS Res Hum Retroviruses ; 17(4): 337-48, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11242520

ABSTRACT

The surface envelope glycoprotein gp46 of the human T cell leukemia virus type 1 elicits a strong immune response. Its protective role against HTLV-1 infection in animal models is well established, suggesting that recombinant envelope glycoproteins or synthetic peptides could be used as an effective vaccine. However, reports have indicated that some variations in envelope sequences may induce incomplete cross-neutralization between HTLV-1 strains. To identify amino acid changes that might be involved in induction of specific neutralizing antibodies, we studied sera from three patients (2085, 2555, and 2709) infected by HTLV-1 with surface glycoprotein gp46 harboring variations in amino acid sequence at positions 39, 72, 265, and 290. Inhibition of syncytia induced by parental, chimeric, or point-mutated envelope proteins indicated that sera 2555 and 2709 primarily recognized neutralizable epitopes located in N- and C-terminal parts of the gp46 glycoprotein. Amino acids changes at positions 39, 265, and 290 greatly impaired recognition of neutralizing epitopes recognized by these two sera. These results demonstrate that amino acid changes in envelope glycoprotein gp46 can induce strain-specific neutralizing antibodies in some patients. On the other hand, the neutralizing activity of serum 2085 was not affected by amino acid changes at positions 39, 265, and 290, suggesting that the neutralizing antibodies present in this serum were directed against epitopes located in other parts of the molecule, possibly those located in the central domain of the molecule, which has the same amino acid sequence in the three viruses.


Subject(s)
Gene Products, env/chemistry , Gene Products, env/immunology , Genetic Variation/genetics , HTLV-I Antibodies/blood , Human T-lymphotropic virus 1/immunology , Retroviridae Proteins, Oncogenic/chemistry , Retroviridae Proteins, Oncogenic/immunology , Amino Acid Sequence , Animals , Cell Line , Gene Products, env/genetics , Giant Cells/physiology , HTLV-I Antibodies/immunology , HTLV-I Antigens/immunology , HTLV-I Infections/immunology , HTLV-I Infections/virology , Humans , Molecular Sequence Data , Mutation , Neutralization Tests , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Retroviridae Proteins, Oncogenic/genetics , Transfection
3.
J Chromatogr B Biomed Sci Appl ; 737(1-2): 85-95, 2000 Jan 14.
Article in English | MEDLINE | ID: mdl-10681045

ABSTRACT

The carboxyl half of the surface envelope protein of HTLV-I contains the major immunodominant and neutralizable domains. Using two affinity chromatography steps and a combination of high salt concentration and non-ionic detergent, we purified this part of the envelope protein from Escherichia coli. Analysis of some immmunological and biological properties of this protein indicated that it was folded in a way that preserved the correct structure of this domain of the HTLV-I envelope protein. It could be utilized in structural studies to further understand the mechanisms of HTLV-I entry and to better define the component(s) of an effective vaccine.


Subject(s)
Human T-lymphotropic virus 1/chemistry , Viral Envelope Proteins/chemistry , Bacteria/genetics , Chromatography, Affinity/methods , Electrophoresis, Polyacrylamide Gel , Genetic Vectors , Giant Cells/cytology , HTLV-I Antibodies/blood , Humans , Protein Folding , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Viral Envelope Proteins/genetics , Viral Envelope Proteins/isolation & purification
4.
J Virol ; 73(11): 9369-76, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10516045

ABSTRACT

The nucleotide sequence of human T-cell leukemia virus type 1 (HTLV-1) is highly conserved, most strains sharing at least 95% sequence identity. This sequence conservation is also found in the viral env gene, which codes for the two envelope glycoproteins that play a major role in the induction of a protective immune response against the virus. However, recent reports have indicated that some variations in env sequences may induce incomplete cross-reactivity between HTLV-1 strains. To identify the amino acid changes that might be involved in the antigenicity of neutralizable epitopes, we constructed expression vectors coding for the envelope glycoproteins of two HTLV-1 isolates (2060 and 2072) which induced human antibodies with different neutralization patterns. The amino acid sequences of the envelope glycoproteins differed at four positions. Vectors coding for chimeric or point-mutated envelope proteins were derived from 2060 and 2072 HTLV-1 env genes. Syncytium formation induced by the wild-type or mutated envelope proteins was inhibited by human sera with different neutralizing specificities. We thus identified two amino acid changes, I173-->V and A187-->T, that play an important role in the antigenicity of neutralizable epitopes located in this region of the surface envelope glycoprotein.


Subject(s)
Antibodies, Viral/immunology , Glycoproteins/immunology , Human T-lymphotropic virus 1/immunology , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/immunology , Amino Acid Sequence , Antibodies, Viral/blood , Cell Line , Cytopathogenic Effect, Viral , Genes, env/genetics , Giant Cells/physiology , Glycoproteins/chemistry , Glycoproteins/genetics , Human T-lymphotropic virus 1/chemistry , Human T-lymphotropic virus 1/genetics , Human T-lymphotropic virus 1/physiology , Humans , Neutralization Tests , Point Mutation , Recombinant Fusion Proteins/immunology , Transfection , Viral Envelope Proteins/genetics
5.
Polit Afr ; (20): 65-77, 1985 Dec.
Article in French | MEDLINE | ID: mdl-12268319

ABSTRACT

PIP: Recent internal migration trends in Burkina Faso are analyzed. The general trend noted is a migration by the Mossi toward the southwest of the country in search of agricultural land. The growing tensions between migrants and the native population of the region are discussed. The role of the state and of policy in this area is considered.^ieng


Subject(s)
Emigration and Immigration , Politics , Population Dynamics , Public Policy , Africa , Africa South of the Sahara , Africa, Northern , Africa, Western , Burkina Faso , Demography , Developing Countries , Population
SELECTION OF CITATIONS
SEARCH DETAIL
...